Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jun 05, 2026
Why Is Arm Holdings plc (ARM) Stock Down -5% Today?

Why Is Arm Holdings plc (ARM) Stock Down -5% Today?

Key Takeaways

  • Shares of ARM are declining approximately 5.00% in premarket trading on June 5, 2026, retreating from the prior session's close of $393.44 to near $373.
  • The primary catalyst is sector-wide pressure stemming from Broadcom's (AVGO) failure to raise its 2026 AI semiconductor revenue forecast, which triggered a broad pullback across high-multiple chip names.
  • Arm had no company-specific negative news; the selloff reflects sympathy weakness from the broader semiconductor complex and profit-taking at elevated valuation levels.
  • Recent insider selling disclosed via SEC filings has added incremental pressure to sentiment during a risk-off rotation.
  • The Philadelphia Semiconductor Index and other AI-infrastructure names declined in parallel, confirming this as a sector-driven move rather than a company-specific event.
  • Traders are monitoring any clarifying commentary from management, the pace of AGI CPU customer ramp-ups, and whether the broader semiconductor selloff stabilizes.

Opening Summary

Arm Holdings plc (ARM) is a Cambridge, England-based semiconductor intellectual property company that designs the CPU architectures used in the vast majority of the world's smartphones, tablets, and increasingly, AI data centers. Shares are declining approximately 5.00% in premarket trading on June 5, 2026, falling from the prior session's closing price of $393.44 to approximately $373 per share. There is no company-specific negative catalyst; the selloff is a sector sympathy move tied to Broadcom's latest earnings update, which rattled investor confidence in near-term AI infrastructure spending momentum across the entire semiconductor complex.

Broadcom's Guidance Disappoints, Weighing on the Sector

The immediate trigger behind ARM's premarket decline is Broadcom's (AVGO) quarterly earnings report, in which the company declined to raise its 2026 AI semiconductor revenue forecast. For a market that had priced in continued acceleration of AI chip demand, Broadcom's static outlook was interpreted as a sign that near-term spending growth may be plateauing — or at least that expectations had run ahead of fundamentals. This dynamic directly pressures high-valuation names like Arm, which trades at a significant premium to traditional semiconductor peers and is particularly exposed to sentiment shifts in the AI infrastructure investment thesis.

Elevated Valuations Amplify the Selloff

ARM shares had surged nearly 90% from the lows earlier in 2026 heading into this session, driven by enthusiasm around its new AGI CPU launch, growing licensing deals with Meta, ByteDance, Oracle, and others, and a $15 billion long-term revenue target for its own chip business. That extraordinary run had pushed the stock's valuation multiples to levels that leave little margin for error — even indirectly negative sector data. When confidence wavers in AI capital expenditure growth, high-multiple AI beneficiaries typically absorb disproportionate selling pressure, as investors rotate toward more defensively positioned names within the technology sector.

Insider Selling Adds to Near-Term Pressure

Adding a secondary layer of caution, recent insider activity at ARM disclosed through SEC Form 4 filings showed selling by company insiders near current elevated price levels. While insider transactions do not necessarily signal bearish conviction from management, they tend to amplify negative sentiment during broader market risk-off episodes, particularly when a stock has appreciated sharply in a short period. In the current context — where the broader chip sector is already under pressure from Broadcom's guidance — the insider selling disclosures provided an additional rationale for short-term traders to reduce exposure.

AGI CPU Demand Remains Solid, But Supply Constraints Linger

It is important to note that Arm's fundamental business trajectory has not changed with today's price action. Management at its last earnings update raised its AGI CPU revenue forecast to $2 billion for fiscal years 2027 and 2028, with a $15 billion annual revenue target within approximately five years. New clients including ByteDance and Oracle were added to the AGI CPU roster as recently as early June. However, the supply-side constraints first flagged during the May 2026 earnings call — specifically, the company's inability to secure sufficient manufacturing capacity to meet all demand — remain an unresolved concern that investors continue to weigh against the strong demand signal.

Market Context and Trading Activity

Today's weakness in ARM is consistent with broad semiconductor sector softness rather than isolated stock-specific deterioration. The Philadelphia Semiconductor Index declined in parallel during the prior session alongside other AI infrastructure names as investors reassessed the pace of AI hardware spending following Broadcom's update. The semiconductor ETF SOXX registered comparable weakness, confirming the sector-wide nature of the rotation. ARM had been trading well above near-term technical support levels after its rapid appreciation from the May lows, and today's pullback represents the stock testing support zones established during that rally. Volume is expected to be elevated relative to Arm's 30-day average given the sector catalyst and the stock's high profile among active traders.

Trending AI Robots

Traders navigating volatile sessions in high-momentum names like ARM may find value in Tickeron's Trending AI Robots page, which highlights the platform's top-performing AI-powered trading bots under current live market conditions. Tickeron operates hundreds of bots covering thousands of tickers, spanning a broad range of strategies, timeframes, performance metrics, and traded instruments — but only the strongest performers rise to the curated Trending section. The featured robots are ranked dynamically, meaning the list reflects what is working in today's market, not historical patterns. For investors and traders seeking systematic, data-driven approaches to managing positions during chip sector volatility, exploring the Trending AI Robots offers a practical starting point.

What Comes Next for ARM

With fiscal year 2026 now closed and reported, ARM's next major earnings event will be its Q1 fiscal 2027 report, expected in late July or early August 2026. That report will be the first true test of whether AGI CPU revenue is materializing at the pace management projected, and whether the supply constraints flagged in May have been resolved. Key variables to monitor include the rate of new AGI CPU customer additions, any updates on manufacturing partnerships with Socionext and TSMC, progress on the $15 billion long-term revenue target, and the trajectory of royalty revenue from the mobile and data center segments. Export control policy around AI CPUs to China — following CEO Rene Haas's comments at Computex that such bans would be impractical — also remains a regulatory wildcard. Broader semiconductor spending trends and the pace of hyperscaler AI infrastructure investment will continue to influence how the market values ARM at its current elevated multiples.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: ARM

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ARM in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 29, 2026

ARM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 16 cases where ARM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ARM's RSI Indicator exited the oversold zone, of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 06, 2026. You may want to consider a long position or call options on ARM as a result. In of 48 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ARM just turned positive on August 04, 2026. Looking at past instances where ARM's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARM advanced for three days, in of 195 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

ARM moved below its 50-day moving average on July 13, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ARM crossed bearishly below the 50-day moving average on July 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ARM entered a downward trend on August 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ARM's P/B Ratio (33.557) is very high in comparison to the industry average of (8.414). P/E Ratio (276.969) is within average values for comparable stocks, (171.289). Projected Growth (PEG Ratio) (2.229) is also within normal values, averaging (1.958). ARM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (56.497) is also within normal values, averaging (58.578).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), Analog Devices (NASDAQ:ADI), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 195.1B. The market cap for tickers in the group ranges from 13.43K to 5.45T. NVDA holds the highest valuation in this group at 5.45T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 5%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 51%. INDI experienced the highest price growth at 27%, while MOBX experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -28% and the average quarterly volume growth was -45%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 52
Price Growth Rating: 47
SMR Rating: 75
Profit Risk Rating: 72
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
ARM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Semiconductors

Profile
Details
Industry
N/A
Address
110 Fulbourn Road
Phone
+44 1223400400
Employees
8330
Web
https://www.arm.com
Interact to see
Advertisement
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion. Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.
Gilead Sciences (GILD): Q4 2025 earnings due February 10, consensus EPS $1.83, revenue $7.68B. Growth driven by HIV franchise; oncology investments like Trodelvy may offer upside. Amgen (AMGN): Reported Q4 2025 EPS $5.29 vs $4.73 expected, revenue $9.9B (+9% YoY). Strong 2026 guidance: $37–38.4B revenue, $21.60–23.00 non-GAAP EPS.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
CME Group delivered record 2025 revenue of $6.52 billion, up 6% year-over-year. Q4 adjusted EPS of $2.77 exceeded expectations.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Q4 2025 revenue reached $12.5 billion, exceeding expectations, with growth portfolio sales up 16% year-over-year. Full-year 2025 revenue totaled $48.2 billion, supported by Eliquis, Opdivo, and newer products including Breyanzi and Camzyos.
KKR reported Q4 2025 adjusted EPS of $1.12, slightly below the $1.14 consensus estimate. The firm raised a record $129 billion in 2025, surpassing 80% of its $300 billion fundraising goal for 2024–2026.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.